Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.371ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.371ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.371ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.371NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HU.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HU.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.625ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.625ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.625ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.625NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.443ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.443ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.443NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.595.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.495ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.495ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used